Friday, November 02, 2018
UMSOM Global Health Expert Named to Prestigious World Health Organization Immunization Panel
Kathleen Neuzil, MD, MPH, Professor of Medicine and Pediatrics and Director of the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine (UMSOM), has been named to the World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) on Immunization.
Sunday, October 28, 2018
American Society of Tropical Medicine & Hygiene Awards Dr. Miriam Laufer the LePrince Medal for Malaria Research
Miriam Laufer, MD, MPH, Professor of Pediatrics and Associate Director for Malaria Research at the University of Maryland School of Medicine’s (UMSOM) Center for Vaccine Development and Global Health (CVD), was awarded the Joseph Augustin LePrince Medal by the American Society of Tropical Medicine and Hygiene (ASTMH).
Wednesday, June 06, 2018
UMSOM Researchers Find that Silent Carriers of Malaria are Unlikely to Develop the Disease
In regions where malaria illness is widespread, it is common to find many individuals who are infected with malaria parasites (Plasmodium falciparum), but without symptoms. New research conducted by the University of Maryland School of Medicine (UMSOM) shows that treating these silent malaria cases could help stop the spread of malaria to others.
Tuesday, May 15, 2018
Tackling Malaria Transmission in Sub-Saharan Africa
Two malaria experts in the Center for Vaccine Development and Global Health at the University of Maryland School of Medicine wrote a commentary published in the June Issue of The Lancet Global Health discussing the prevalence of malaria in school-age children in sub-Saharan Africa. Miriam Laufer, MD, Associate Professor of Pediatrics and Associate Director for Malaria Research CVD, and Lauren Cohee, MD, Instructor, Pediatrics, noted that often malaria infection is more common in school-age children than younger children and adults.
Monday, May 14, 2018
New Research: Some Gut Bacteria May Protect Against Intestinal Infection
Scientists at the University of Maryland School of Medicine (UMSOM) have for the first time found evidence that the presence of a key species in the human gut microbiome is associated with protection from infection with typhoid fever. If the research is borne out, it could offer an exciting new way to reduce intestinal infections from microbes.
Friday, May 11, 2018
Honoring Dr. Robert Edelman for Three Decades of Service at UMSOM
Dr. Robert Edelman’s legacy will live long past his tenure at the Center for Vaccine Development and Global Health (CVD). Prior to an esteemed career in academia, he served in the military and the US public health service.
Thursday, May 03, 2018
Low Efficacy Influenza Vaccines Can Still Significantly Avert Infections, Study Shows
Research published in PNAS, showed that even less effective influenza vaccines can still help to reduce illnesses, hospitalizations and other issues as long as the vaccine is broadly administered across age groups.
Tuesday, May 01, 2018
CVD Global Health Seminar: The Universal Challenge of Influenza
Join us for a discussion on developing an influenza challenge model.
Monday, April 23, 2018
UM School of Medicine Launches Newly Organized Center for Vaccine Development and Global Health Under Leadership of International Vaccine Expert Dr. Kathleen Neuzil
University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today the launch of a newly organized Center for Vaccine Development and Global Health (CVD). The new Center will be led by UMSOM Professor of Medicine and Pediatrics, Kathleen Neuzil, MD MPH, FIDSA, one of the world’s most influential research scientists and advocates in vaccine development and policy.
Friday, April 20, 2018
Tuberculosis Vaccines: The End of the Beginning
Monday, Apr. 30, 2018, Noon - 1 p.m., HSF II Auditorium, 20 Penn Street. Join us on April 30 for a discussion on Turbulosis vaccines. Our Speaker: Chetan Seshadri, MD, Assistant Professor, Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington.
Tuesday, April 03, 2018
The WHO just updated its typhoid position paper for the first time in 10 years. The change? Typhoid conjugate vaccines are now formally recommended for routine childhood immunization!
Tuesday, March 20, 2018
UMSOM Vaccine Experts Lead Trial on Avian Flu Vaccine
Vaccine experts at the University of Maryland School of Medicine (UMSOM) have begun multiple clinical trials of vaccines designed to protect against H7N9, an avian influenza virus that was first reported in humans in 2013 in China.
Monday, March 19, 2018
Global Health Seminar
Join us for a discussion on "Typhoid Fever: Modeling the Impact of New Strategies Against an Old Foe." Our speaker for this event is Virginia Elizabeth Pitzer, ScD, Co-Director, Public health Modeling Concentration at Yale School of Public Health.
Friday, March 09, 2018
Congratulations to Kathy Neuzil: Named one of the Daily Record' Top 100 Women in Maryland
The Daily Record has announced the honorees of its 2018 Maryland’s Top 100 Women awards. Fourteen women will be inducted into the Circle of Excellence, receiving the award for a third and final time.
Monday, March 05, 2018
Brushing Up On Clinical Research Conduct and Ethics?
Did you know that the CVD’s Drs. Edelman and Campbell work one-on-one with Principal Investigators (PIs) to solve unique scientific and regulatory dilemmas associated with their research protocols? Specifically, they help researchers design, write, and organize research protocols in compliance with institutional review board (IRB) policies and regulations and submit new or revised protocols to the IRB.
Thursday, March 01, 2018
Did You Know It Costs $3000 To Ship An Ultrasound To Uganda?
Help support CVD alumni and 4th year SOM student, Sara Budava, PhD
Friday, February 23, 2018
UMSOM Vaccine Expert Highlights Need for Vaccination Among Older Adults During Capitol Hill Briefing
Today at a briefing on Capitol Hill, Wilbur Chen, MD, MS, Associate Professor of Medicine at the University of Maryland School of Medicine, warned that the U.S. population of adults 65 and older is expected to rise significantly over the next few decades, making vaccinations against diseases like influenza, pneumonia and shingles for this population very critical.
Wednesday, February 21, 2018
First child vaccinated with typhoid conjugate vaccine in Africa
History was made in the fight against typhoid fever today, as the first child in Africa was vaccinated in a clinical trial using a new generation of typhoid vaccines. The clinical trial in Malawi is being led by Professor Melita Gordon of the University of Liverpool and the Malawi-Liverpool-Wellcome Trust (MLW) Clinical Research Programme.
Friday, February 09, 2018
VIDA Independent Scientific Advisory Committee Meeting
Researchers from the Rotavirus Vaccine Impact on Diarrhea in Africa (VIDA) study met with the International Strategic Advisory Committee (ISAC) overseeing the project, along with representatives from PATH and the Bill & Melinda Gates Foundation (the Foundation) in Seattle, WA last week to review the overall progress and plans of the project.
Friday, January 19, 2018
Global Health Seminar: Primary Health Care in Low Resource Settings
Monday, Feb. 19, 2018, Noon - 1 p.m., HSF-II Auditorium. Join us for a discussion about examining the evidence and solutions for primary health care in low resource settings. Our speaker for this event is Kenneth Leonard, Ph.D., Associate Professor, Agricultural and Resource Economics, University of Maryland College Park.
Thursday, January 04, 2018
Kathleen Neuzil, MD, MPH on Influenza: The Master of Mutation
We’ve heard it over and over: get your flu shot. If you’re older than six months, get your shot. The flu can be more than uncomfortable -- it can be fatal. What goes into the shot that inoculates against the virus? And why do we need a new one each year? Dr. Kathleen Neuzil, Professor and Director at the Center for Vaccine Development of the University of Maryland Medical School, tells us why the influenza virus is a master of mutation, modifying its proteins as it replicates from season to season.
Thursday, January 04, 2018
Kathleen Neuzil, MD, MPH featured in Uncovering Advantages of the New Typhoid Vaccine.
Yesterday’s announcement that WHO has prequalified the first conjugate vaccine for typhoid offers a major boost to prevention efforts against a disease that causes 11–20 million cases annually and up to 161,000 deaths.